मूलभूत आँकड़े
| CIK | 1777921 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to AvePoint, Inc. - Equity Warrant
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| August 7, 2025 |
EXHIBIT 99.1 AvePoint Announces Second Quarter 2025 Financial Results Total quarterly revenue surpassed $100 million for the first time Second quarter SaaS revenue of $77.3 million, representing 44% year-over-year growth, 40% on a constant currency basis Second quarter Total revenue of $102.0 million, representing 31% year-over-year growth, 27% on a constant currency basis Total ARR of $367.6 mill |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 A |
|
| July 16, 2025 |
AvePoint Announces Redemption of Outstanding Public Warrants Exhibit 99.1 AvePoint Announces Redemption of Outstanding Public Warrants JERSEY CITY, N.J., July 16, 2025 (GLOBE NEWSWIRE) – AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that it has completed the redemption of its publicly traded warrants (the “Warrants”) to purchase shares of AvePoint’s common stock, $0.0001 par value per share (“Common |
|
| July 16, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2025 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction (Commission File Number) (IRS Employer I |
|
| June 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2025 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction (Commission File Numb |
|
| June 11, 2025 |
AMENDED NOTICE OF REDEMPTION OF PUBLIC WARRANTS (CUSIP 053604112) Exhibit 99.1 June 11, 2025 AMENDED NOTICE OF REDEMPTION OF PUBLIC WARRANTS (CUSIP 053604112) Dear Warrant Holder, AvePoint, Inc. (the “Company”) previously gave notice on June 9, 2025, and hereby gives amended notice, that it is redeeming, at 5:00 p.m. New York City time on July 11, 2025 (the “Redemption Date”), all of the Company’s outstanding public warrants (the “Warrants”) to purchase shares o |
|
| June 10, 2025 |
NOTICE OF REDEMPTION OF PUBLIC WARRANTS (CUSIP 053604112) Exhibit 99.1 June 9, 2025 NOTICE OF REDEMPTION OF PUBLIC WARRANTS (CUSIP 053604112) Dear Warrant Holder, AvePoint, Inc. (the “Company”) hereby gives notice that it is redeeming, at 5:00 p.m. New York City time on July 9, 2025 (the “Redemption Date”), all of the Company’s outstanding public warrants (the “Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the |
|
| June 10, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2025 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction (Commission File Number) (IRS Employer Id |
|
| May 8, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 8, 2025 |
EXHIBIT 99.1 AvePoint Announces First Quarter 2025 Financial Results First quarter SaaS revenue of $68.9 million, representing 34% year-over-year growth, 37% on a constant currency basis First quarter Total revenue of $93.1 million, representing 25% year-over-year growth, 27% on a constant currency basis Total ARR of $345.5 million, representing 26% year-over-year growth, 28% adjusted for FX JERSE |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 |
|
| May 1, 2025 |
May 1, 2025 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: AvePoint, Inc. Request to Withdraw Registration Statement on Form S-8 Filed April 17, 2025 Registration No. 333-286606 Ladies and Gentlemen: Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), AvePoint, Inc. (the “Company”) hereby respectfully req |
|
| May 1, 2025 |
Form of PSU Grant Package under AvePoint, Inc. 2021 Equity Incentive Plan. Exhibit 99.4 AVEPOINT, INC. March 2025 PSU AWARD GRANT NOTICE (2021 EQUITY INCENTIVE PLAN) AvePoint, Inc. (the “Company”) has awarded to you (the “Participant”) the number of performance-based restricted stock units specified and on the terms set forth below in consideration of your services (the “PSU Award”). Your PSU Award is subject to all of the terms and conditions as set forth herein and in |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 83-4461709 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 525 Washington Blvd, Suite 1400 Jersey City, NJ (Address of principal executive offices) 073 |
|
| May 1, 2025 |
Exhibit 107 Calculation of Filing Fee Tables S-8 AvePoint, Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.0001 per share Other 37,291,113(2) $ 15.50(3) $ 578,012,251.50 0.0001531 $ |
|
| April 17, 2025 |
Form of PSU Grant Package under AvePoint, Inc. 2021 Equity Incentive Plan. AVEPOINT, INC. March 2025 PSU AWARD GRANT NOTICE (2021 EQUITY INCENTIVE PLAN) AvePoint, Inc. (the “Company”) has awarded to you (the “Participant”) the number of performance-based restricted stock units specified and on the terms set forth below in consideration of your services (the “PSU Award”). Your PSU Award is subject to all of the terms and conditions as set forth herein and in the Company’s |
|
| April 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 83-4461709 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 525 Washington Blvd, Suite 1400 Jersey City, NJ (Address of principal executive offices) 073 |
|
| April 17, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) AvePoint, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Amount Registered (1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.0001 per share 37,291,113 |
|
| March 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)( |
|
| March 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)( |
|
| February 28, 2025 |
Employment Agreement, dated February 25, 2025, by and between AvePoint and James Caci. Exhibit 10.13 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is entered into as of the 25th day of February, 2025 (the “Effective Date”), by and between James Caci (the “Employee”) and AvePoint, Inc. (the “Company”). Employee has been employed by AvePoint, Inc. as its Chief Financial Officer pursuant to an Employment Agreement with AvePoint, Inc. dated August 11, 2021 (the “Prior |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 AvePo |
|
| February 28, 2025 |
Exhibit 19.1 AVEPOINT, INC. INSIDER TRADING POLICY Last Updated and Approved: August 20, 2024 A. Introduction. During the course of your relationship with AvePoint, Inc., a Delaware corporation or any of its subsidiaries (collectively, the “Company”), you may receive important material information that is not yet publicly available (“inside information” or “MNPI”) about the Company or about other |
|
| February 28, 2025 |
Exhibit 21.1 AvePoint, Inc. List of Material Subsidiaries Subsidiary Jurisdiction AvePoint AU Pty Ltd. Australia AvePoint Canada Ltd. Canada AvePoint Beijing Technology Ltd. China AvePoint Technology Changchun Co. Ltd. China Shanghai AvePoint Software Technology Corporation Limited China AvePoint France* France AvePoint Deutschland GmbH Germany AvePoint Japan K.K. Japan AvePoint Korea Co. Ltd. Kor |
|
| February 27, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| February 27, 2025 |
EXHIBIT 99.1 AvePoint Announces Fourth Quarter and Full Year 2024 Financial Results Full year SaaS revenue of $230.7 million, representing 43% year-over-year growth, 44% on a constant currency basis Full year Total revenue of $330.5 million, representing 22% year-over-year growth, 22% on a constant currency basis Total ARR of $327.0 million, representing 24% year-over-year growth, 25% adjusted for |
|
| November 7, 2024 |
EXHIBIT 99.1 AvePoint Announces Third Quarter 2024 Financial Results Third quarter SaaS revenue of $60.9 million, representing 45% year-over-year growth Third quarter Total revenue of $88.8 million, representing 22% year-over-year growth Total ARR of $308.9 million, representing 23% year-over-year growth JERSEY CITY, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) - AvePoint (NASDAQ: AVPT), the global leader |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39 |
|
| September 26, 2024 |
As filed with the U.S. Securities and Exchange Commission on September 26, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) AVEPOINT, INC. (Name of Subject Company (Issuer)) AVEPOINT, INC. (Offeror) (Names of Filing Persons (Identifying Status a |
|
| September 26, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2024 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| September 26, 2024 |
EX-99.1 2 ex727779.htm EXHIBIT 99.1 Exhibit 99.1 AvePoint Announces Expiration and Results of the Offer to Purchase and Consent Solicitation Relating to its Warrants JERSEY CITY, NJ – SEPTEMBER 26, 2024 — AvePoint, Inc. (“AvePoint” or the “Company”) (Nasdaq: AVPT, AVPTW), the global leader in robust data management and data governance, today announced the expiration of its offer to purchase (the “ |
|
| September 9, 2024 |
SC TO-I/A 1 avpt20240909sctoia.htm As filed with the U.S. Securities and Exchange Commission on September 9, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) AVEPOINT, INC. (Name of Subject Company (Issuer)) AVEPOINT, INC. (Offeror) (Names of Fi |
|
| September 9, 2024 |
John T. McKenna T: +1 650 843 5059 [email protected] September 9, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Blake Grady Re: AvePoint, Inc. Schedule TO-I filed August 27, 2024 File No. 005-91137 Dear Mr. Grady: I am writing on behalf of AvePoint, Inc. (the “Company”) in response to the comments of th |
|
| August 27, 2024 |
Exhibit (a)(1)(E) Offer to Purchase Warrants to Acquire Shares of Common Stock of AvePoint, Inc. |
|
| August 27, 2024 |
Presentation of Evercore Group L.L.C., August 2024. Exhibit (c) |
|
| August 27, 2024 |
Offer to Purchase and Consent Solicitation, dated August 27, 2024. Exhibit (a)(1)(A) OFFER TO PURCHASE BY AVEPOINT, INC. OF UP TO 17,576,241 OF ITS WARRANTS TO PURCHASE SHARES OF COMMON STOCK AT A PURCHASE PRICE OF $2.50 IN CASH PER WARRANT AND CONSENT SOLICITATION THE OFFER PERIOD AND YOUR RIGHT TO WITHDRAW WARRANTS THAT YOU TENDER WILL EXPIRE AT 12:00 MIDNIGHT, EASTERN TIME, AT THE END OF THE DAY ON SEPTEMBER 24, 2024, UNLESS THE OFFER PERIOD IS EXTENDED. THE C |
|
| August 27, 2024 |
As filed with the Securities and Exchange Commission on August 27, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 27, 2024 |
Form of Notice of Guaranteed Delivery. Exhibit (a)(1)(C) NOTICE OF GUARANTEED DELIVERY OF WARRANTS OF AVEPOINT, INC. PURSUANT TO THE OFFER DATED AUGUST 27, 2024 This Notice of Guaranteed Delivery, or one substantially in the form hereof, must be used to accept the Offer (as defined below) if: ● Warrants (as defined below) are not immediately available or Warrant holders cannot deliver Warrants to Continental Stock Transfer & Trust Comp |
|
| August 27, 2024 |
Exhibit (a)(1)(D) Offer to Purchase Warrants to Acquire Shares of Common Stock of AvePoint, Inc. |
|
| August 27, 2024 |
Exhibit (a)(1)(B) LETTER OF TRANSMITTAL AND CONSENT Offer To Purchase Warrants to Acquire Shares of Common Stock of AVEPOINT, INC. |
|
| August 27, 2024 |
Press Release, dated August 27, 2024, announcing cash tender offer for AvePoint, Inc. warrants. Exhibit (a)(5) AvePoint Announces Commencement of an Offer to Purchase and Consent Solicitation Relating to its Warrants JERSEY CITY, NJ – AUGUST 27, 2024 — AvePoint (Nasdaq: AVPT, AVPTW), the global leader in robust data management and data governance, today announced that it has commenced an offer to purchase (the “Offer”) all of its outstanding public warrants (the “Warrants”) to purchase shares of its common stock, par value $0. |
|
| August 27, 2024 |
Ex-Filing Fees CALCULATION OF FILING FEE TABLES Schedule TO (Form Type) AvePoint, Inc. |
|
| August 8, 2024 |
EXHIBIT 99.1 AvePoint Announces Second Quarter 2024 Financial Results Second quarter SaaS revenue of $53.6 million, representing 40% year-over-year growth Second quarter Total revenue of $78.0 million, representing 20% year-over-year growth Total ARR of $290.1 million, representing 23% year-over-year growth JERSEY CITY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) - AvePoint (NASDAQ: AVPT), the global lea |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 A |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| May 9, 2024 |
Exhibit 10.1 Subscription Deed A3 Ventures Fund 1 L.P. Details Parties General Partner and Subscriber General Partner Name A3V GP Co, a Cayman Islands exempted company as the general partner of A3 Ventures Fund 1 L.P. Company number 399015 Incorporated in Cayman Islands Address CO Services Cayman Limited, P.O. Box 10008, Willow House, Cricket Square, Grand Cayman, KY1-1001, Cayman Islands Email [R |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 9, 2024 |
EXHIBIT 99.1 AvePoint Announces First Quarter 2024 Financial Results First quarter SaaS revenue of $51.3 million, representing 44% year-over-year growth First quarter Total revenue of $74.5 million, representing 25% year-over-year growth Total ARR of $274.5 million, representing 23% year-over-year growth JERSEY CITY, N.J., May 09, 2024 (GLOBE NEWSWIRE) - AvePoint (NASDAQ: AVPT), a global leader in |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 |
|
| May 9, 2024 |
Third Amended and Restated Certificate of Incorporation EXHIBIT 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AVEPOINT, INC. May 7, 2024 AvePoint, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (as it now exists or may hereafter be amended and supplemented, the “DGCL”), does hereby certify that: ONE: The original Certificate of Incorporation of Apex Technology Acquisition Corporati |
|
| May 9, 2024 |
UNITED STATES -12-31 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 (May 7, 2024) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (Co |
|
| April 15, 2024 |
PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 Up to 130,532,274 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This Prospectus relates to the issuance by us of an aggregate of up to 17,905,000 shares of our Common Stock, $0.0001 par value per share (the “Common Stock”), whic |
|
| April 8, 2024 |
As filed with the U.S. Securities and Exchange Commission on April 5, 2024 As filed with the U.S. Securities and Exchange Commission on April 5, 2024 Registration No. 333-258109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1 ON FORM S-3 REGISTRATION STATEMENT Under the Securities Act of 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 7379 83-4461709 (State or other jur |
|
| April 8, 2024 |
EXHIBIT 107 Calculation of Filing Fee Table Post-Effective Amendment No. 3 to Form S-1 on Form S-3 (Form Type) AvePoint, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering P |
|
| April 1, 2024 |
EXHIBIT 107 Calculation of Filing Fee Table Post-Effective Amendment No. 3 to Form S-1 on Form S-3 (Form Type) AvePoint, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering P |
|
| April 1, 2024 |
As filed with the U.S. Securities and Exchange Commission on April 1, 2024 As filed with the U.S. Securities and Exchange Commission on April 1, 2024 Registration No. 333-258109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 ON FORM S-3 REGISTRATION STATEMENT Under the Securities Act of 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 7379 83-4461709 (State or other jur |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)( |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)( |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)( |
|
| March 4, 2024 |
AvePoint 2021 Equity Incentive Plan. EXHIBIT 10.12 AvePoint, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: July 1, 2021 Approved by the Stockholders: June 30, 2021 1. General. (a) Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Aff |
|
| March 4, 2024 |
Table of Contents PROSPECTUS SUPPLEMENT NO. 3 Filed Pursuant to Rule 424(b)(3) (To the Prospectus dated July 7, 2023) Registration No. 333-258109 Up to 130,532,274 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This Prospectus relates to the issuance by us of an aggregate of up to 17,905,000 shares o |
|
| March 4, 2024 |
Exhibit 21.1 AvePoint, Inc. List of Material Subsidiaries Subsidiary Jurisdiction AvePoint AU Pty Ltd. Australia tyGraph Ltd. Canada AvePoint Beijing Technology Ltd. China AvePoint Technology Changchun Co. Ltd. China Shanghai AvePoint Software Technology Corporation Limited China AvePoint France* France AvePoint Deutschland GmbH Germany AvePoint Japan K.K. Japan AvePoint Korea Co. Ltd. Korea AvePo |
|
| February 29, 2024 |
EXHIBIT 97.1 AVEPOINT, INC. COMPENSATION RECOVERY POLICY Approved: September 7, 2023 AvePoint, Inc., a Delaware corporation, (collectively with its subsidiaries and other affiliates, the “Company”) is committed to promoting high standards of honest and ethical business conduct and compliance with applicable laws, rules and regulations. As part of this commitment, the Company has adopted this Compe |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 AvePo |
|
| February 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| February 29, 2024 |
AvePoint 2021 Equity Incentive Plan. EXHIBIT 10.12 AvePoint, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: July 1, 2021 Approved by the Stockholders: June 30, 2021 1. General. (a) Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Aff |
|
| February 29, 2024 |
EXHIBIT 99.1 AvePoint Announces Fourth Quarter and Full Year 2023 Financial Results Full year SaaS revenue of $161.0 million, representing 37% year-over-year growth Full year Total revenue of $271.8 million, representing 17% year-over-year growth Total ARR of $264.5 million, representing 23% year-over-year growth, 24% adjusted for FX JERSEY CITY, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) - AvePoint (NA |
|
| February 29, 2024 |
AvePoint, Inc. List of Material Subsidiaries Exhibit 21.1 AvePoint, Inc. List of Material Subsidiaries Subsidiary Jurisdiction AvePoint AU Pty Ltd. Australia tyGraph Ltd. Canada AvePoint Beijing Technology Ltd. China AvePoint Technology Changchun Co. Ltd. China Shanghai AvePoint Software Technology Corporation Limited China AvePoint France* France AvePoint Deutschland GmbH Germany AvePoint Japan K.K. Japan AvePoint Korea Co. Ltd. Korea AvePo |
|
| February 13, 2024 |
AVPT / AvePoint, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: AvePoint, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 053604104 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| November 13, 2023 |
PROSPECTUS SUPPLEMENT NO. 2 Filed Pursuant to Rule 424(b)(3) (To the Prospectus dated July 7, 2023) Registration No. 333-258109 Up to 130,532,274 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This Prospectus relates to the issuance by us of an aggregate of up to 17,905,000 shares of our Common Stock |
|
| November 9, 2023 |
EXHIBIT 99.1 AvePoint Announces Third Quarter 2023 Financial Results Third quarter SaaS revenue of $41.9 million, representing 40% year-over-year growth Third quarter Total revenue of $72.8 million, representing 16% year-over-year growth Total ARR of $250.6 million, representing 23% year-over-year growth, 25% adjusted for FX JERSEY CITY, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) - AvePoint (NASDAQ: AVP |
|
| November 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39 |
|
| November 6, 2023 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2023 (November 3, 2023) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) |
|
| November 6, 2023 |
Exhibit 10.3 EXECUTION VERSION REVOLVING NOTE $30,000,000 New York, New York November 3, 2023 FOR VALUE RECEIVED, the undersigned, AVEPOINT, INC. (“Borrower”), hereby unconditionally promises to pay, on or before the Revolving Maturity Date, to the order of HSBC Bank USA, National Association (“Bank”) at 452 Fifth Avenue, New York, NY 10018, Attn: Jan Luehrs, or at the holder’s option, at such oth |
|
| November 6, 2023 |
Exhibit 10.2 EXECUTION VERSION PLEDGE AGREEMENT THIS PLEDGE AGREEMENT (this “Agreement”) is entered into as of November 3, 2023, by and among AvePoint, Inc., a Delaware corporation (“Borrower”), certain Subsidiaries of Borrower as Loan Parties from time to time party thereto (together with the Borrower, each, a “Pledgor” and together, “Pledgors”), and HSBC Bank USA, National Association (“Bank”). |
|
| November 6, 2023 |
Exhibit 10.1 EXECUTION VERSION LOAN AND SECURITY AGREEMENT This LOAN AND SECURITY AGREEMENT (this “Agreement”) is entered into as of November 3, 2023, by and among HSBC BANK USA, NATIONAL ASSOCIATION (together with its successors and assigns, “Bank”), AVEPOINT, INC., a Delaware corporation (“Borrower”) and each of the Guarantors (as defined below) party hereto from time to time. RECITALS Borrower |
|
| September 25, 2023 |
EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G, dated September 25, 2023 (the “Schedule 13G”), with respect to the Common Stock, par value $0.0001 per share, of AvePoint, Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under t |
|
| September 25, 2023 |
AVPT / AvePoint Inc - Class A / Anchor IV Pte. Ltd. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* AvePoint, Inc. (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 053604104 (CUSIP Number |
|
| September 18, 2023 |
EX-99.1 2 ex99-1.htm PURCHASE AGREEMENT Sixth Street Partners Management Company, L.P. SC 13D/A Exhibit 1 PURCHASE AGREEMENT PURCHASE AGREEMENT, dated as of September 15, 2023 (this “Agreement”), by and between Anchor IV Pte. Ltd., a company organized under the laws of Singapore (the “Purchaser”), and Avatar Investment Solutions (A), LLC, a limited liability company organized under the laws of the |
|
| September 18, 2023 |
SC 13D/A 1 avepoint-sc13da091523.htm AMENDMENT TO FORM SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* AvePoint, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 053604104 (CUSIP Number) Joshua Peck c/o Sixth Street Partners, LLC 2100 McKinney Avenue Suite 1500 Dallas, TX 75201 |
|
| August 10, 2023 |
PROSPECTUS SUPPLEMENT NO. 1 Filed Pursuant to Rule 424(b)(3) (To the Prospectus dated July 7, 2023) Registration No. 333-258109 Up to 130,532,274 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This Prospectus relates to the issuance by us of an aggregate of up to 17,905,000 shares of our Common Stock |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 9, 2023 |
EXHIBIT 99.1 AvePoint Announces Second Quarter 2023 Financial Results Second quarter SaaS revenue of $38.3 million, representing 39% year-over-year growth Second quarter Total revenue of $64.9 million, representing 16% year-over-year growth Total ARR of $236.2 million, representing 26% year-over-year growth, 30% adjusted for FX impact JERSEY CITY, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) - AvePoint (N |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 A |
|
| July 7, 2023 |
PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 Up to 130,532,274 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This Prospectus relates to the issuance by us of an aggregate of up to 17,905,000 shares of our Common Stock, $0.0001 par value per share (the “Common Stock”), whic |
|
| June 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* AvePoint, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 053604104 (CUSIP Number) Joshua Peck c/o Sixth Street Partners, LLC 2100 McKinney Avenue Suite 1500 Dallas, TX 75201 469-621-3001 (Name, Address and Telephone Number of Person Au |
|
| June 14, 2023 |
As filed with the U.S. Securities and Exchange Commission on June 13, 2023 As filed with the U.S. Securities and Exchange Commission on June 13, 2023 Registration No. 333-258109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3 ON FORM S-1 REGISTRATION STATEMENT Under the Securities Act of 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 7379 83-4461709 (State or other jur |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 -12-31FY2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: |
|
| June 8, 2023 |
June 8, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology Washington, DC 20549 Attention: Stephen Krikorian, Accounting Branch Chief Ryan Rohn, Senior Staff Accountant Re: AvePoint, Inc. Form 10-K for the Fiscal Year ended December 31, 2022 Filed March 31, 2023 File No. 001-39048 Dear Mr. Krikorian and Mr. Rohn: This letter sets forth the r |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2023 (May 16, 2023) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (Commiss |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 |
|
| May 10, 2023 |
EXHIBIT 99.1 AvePoint Announces First Quarter 2023 Financial Results First quarter SaaS revenue of $35.5 million, representing 34% year-over-year growth, 39% adjusted for constant currency First quarter Total revenue of $59.6 million, representing 18% year-over-year growth, 23% adjusted for constant currency Total ARR of $222.4 million, representing 26% year-over-year growth, 31% adjusted for FX i |
|
| May 8, 2023 |
As filed with the U.S. Securities and Exchange Commission on May 5, 2023 As filed with the U.S. Securities and Exchange Commission on May 5, 2023 Registration No. 333-258109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 ON FORM S-1 REGISTRATION STATEMENT Under the Securities Act of 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 7379 83-4461709 (State or other juris |
|
| March 31, 2023 |
Amended and Restated Bylaws of AvePoint, Inc. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF AVEPOINT, INC. As adopted on March 29, 2023 AMENDED AND RESTATED BYLAWS OF AVEPOINT, INC. (a Delaware corporation) TABLE OF CONTENTS ARTICLE I OFFICES 1 1.1 Registered Office 1 1.2 Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 Location 1 2.2 Annual Meetings 1 2.3 Special Meetings. 1 2.4 Notice of Meeting 2 2.5 Stockholders’ Records 2 2.6 Quorum; Mee |
|
| March 31, 2023 |
Exhibit 21.1 AvePoint, Inc. List of Material Subsidiaries Subsidiary Jurisdiction AvePoint AU Pty Ltd. Australia AvePoint Beijing Technology Ltd. China AvePoint Benelux Netherlands AvePoint Canada Ltd. Canada AvePoint Deutschland GmbH Germany MaivenPoint Pte. Ltd. Singapore AvePoint France France AvePoint Holding Limited United Kingdom AvePoint Holdings USA, LLC Virginia (United States) AvePoint J |
|
| March 31, 2023 |
2022 Performance-Based Annual Incentive Plan Exhibit 10.29 AVEPOINT, INC. 2022 PERFORMANCE-BASED ANNUAL INCENTIVE PLAN 1. Purpose The purpose of this 2022 Performance-Based Annual Incentive Plan (the “Bonus Plan”) is to advance the interests of AvePoint, Inc. (the “Company”) and its stockholders by providing eligible employees with annual incentive compensation opportunities that are tied to the achievement of performance goals. The Bonus Pl |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 AvePo |
|
| March 31, 2023 |
Exhibit 4.3 DESCRIPTION OF CAPITAL STOCK The following is a description of the material terms of the capital stock of AvePoint, Inc. (the “Company”). This description is not complete and is qualified by reference to the complete text of the Company’s second amended and restated certificate of incorporation (the “Certificate of Incorporation”) and amended and restated bylaws (the “Bylaws”) filed as |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)( |
|
| March 24, 2023 |
DEF 14A 1 avpt20230323def14a.htm FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of C |
|
| March 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| March 9, 2023 |
EXHIBIT 99.1 AvePoint Announces Fourth Quarter and Full Year 2022 Financial Results Full year SaaS revenue of $117.2 million, representing 37% year-over-year growth, 46% adjusted for constant currency Full year total revenue of $232.3 million, representing 21% year-over-year growth, 29% adjusted for constant currency Total ARR of $201.7 million, representing 27% year-over-year growth, 32% adjusted |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2023 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2023 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| February 9, 2023 |
AVPT / AvePoint, Inc. Class A / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: AvePoint Inc. Title of Class of Securities: Common Stock CUSIP Number: 053604104 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d- |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39 |
|
| November 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| November 10, 2022 |
EXHIBIT 99.1 AvePoint Announces Third Quarter 2022 Financial Results Third quarter SaaS revenue of $30.0 million, representing 34% year-over-year growth, 45% adjusted for constant currency Third quarter total revenue of $62.7 million, representing 16% year-over-year growth, 26% adjusted for constant currency Total ARR of $191.7 million, representing 30% year-over-year growth, 34% adjusted for FX i |
|
| August 31, 2022 |
PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 Up to 130,532,274 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 76,250 Warrants to Purchase Common Stock This Prospectus relates to the issuance by us of an aggregate of up to 17,905,000 shares of our Common Stock, $0.0001 par value per share (the ?Common Stock?), which |
|
| August 25, 2022 |
As filed with the U.S. Securities and Exchange Commission on August 25, 2022 As filed with the U.S. Securities and Exchange Commission on August 25, 2022 Registration No. 333-258109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 ON FORM S-3 REGISTRATION STATEMENT Under the Securities Act of 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 7379 83-4461709 (State or other j |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 A |
|
| August 11, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2022 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| August 11, 2022 |
EXHIBIT 99.1 AvePoint Announces Second Quarter 2022 Financial Results Second quarter SaaS revenue of $27.6 million, representing 34% year-over-year growth, 43% adjusted for constant currency Second quarter total revenue of $55.7 million, representing 23% year-over-year growth, 31% adjusted for constant currency Total ARR of $178.2 million, representing 28% year-over-year growth, 29% adjusted for F |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 |
|
| May 16, 2022 |
424B3 1 avpt20220516424b3.htm FORM 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 PROSPECTUS SUPPLEMENT NO. 7 (To the Prospectus dated August 9, 2021) Up to 136,035,264 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated Augu |
|
| May 12, 2022 |
EXHIBIT 99.1 AvePoint Announces First Quarter 2022 Financial Results First quarter SaaS revenue of $26.6 million, up 45% year-over-year First quarter total revenue of $50.3 million, up 30% year-over-year Total ARR of $167.4 million, up 30% year-over-year JERSEY CITY, N.J., May 12, 2022 (GLOBE NEWSWIRE) - AvePoint (NASDAQ: AVPT), the most advanced SaaS and data management platform provider, today a |
|
| May 12, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2022 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2022 (May 3, 2022) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (Commissio |
|
| April 5, 2022 |
As filed with the U.S. Securities and Exchange Commission on April [__], 2022 As filed with the U.S. Securities and Exchange Commission on April [], 2022 Registration No. 333-258109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT Under the Securities Act of 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 7379 83-4461709 (State or other jurisdiction o |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39048 AvePo |
|
| March 24, 2022 |
Notice of Annual Meeting of Stockholders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ?? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e) |
|
| March 17, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2022 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| March 17, 2022 |
Exhibit 99.1 AvePoint Announces Fourth Quarter and Full Year 2021 Financial Results and $150 Million Share Repurchase Program Full year SaaS revenue of $85.6 million, up 64% year-over-year Total ARR of $159.2 million, up 34% year-over-year Cloud user base exceeds 9 million JERSEY CITY, N.J., March 17, 2022 (GLOBE NEWSWIRE) - AvePoint (NASDAQ: AVPT), the most advanced SaaS and data management solut |
|
| November 16, 2021 |
424B3 1 avpt20211115b424b3.htm FORM 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 PROSPECTUS SUPPLEMENT NO. 6 (To the Prospectus dated August 9, 2021) Up to 136,035,264 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated Aug |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-39 |
|
| November 15, 2021 |
AvePoint Announces Third Quarter 2021 Financial Results EXHIBIT 99.1 AvePoint Announces Third Quarter 2021 Financial Results JERSEY CITY, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) - AvePoint, Inc. (NASDAQ: AVPT), the largest data management solutions provider for Microsoft 365, today announced financial results for the third quarter ended September 30, 2021. "AvePoint delivered its eleventh consecutive record quarter with total revenue of $54 million and 79 |
|
| November 15, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2021 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 2, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 PROSPECTUS SUPPLEMENT NO. 5 (To the Prospectus dated August 9, 2021) Up to 136,035,264 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 9, 2021 (the ?Prospectus?), which form |
|
| November 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2021 (October 31, 2021) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) |
|
| November 1, 2021 |
Exhibit 10.9 Annex A LOAN AND SECURITY AGREEMENT This LOAN AND SECURITY AGREEMENT (this ?Agreement?) is entered into as of April 7, 2020, by and among HSBC Ventures USA Inc. (together with its successors and assigns, ?Bank?), AVEPOINT, INC. (f/k/a Apex Technology Acquisition Corporation and successor by merger to AvePoint US, LLC), a Delaware corporation (?Borrower?), and each of the Guarantors (a |
|
| November 1, 2021 |
Exhibit 10.8 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT, dated as of October 31, 2021 (this ?Amendment?), among AVEPOINT, INC. (f/k/a Apex Technology Acquisition Corporation and successor by merger to AvePoint US, LLC), a Delaware corporation (?Borrower?), the guarantors party hereto, and HSBC VENTURES USA INC. (together with its successors and |
|
| September 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 83-4461709 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 525 Washington Blvd, Suite 1400 Jersey City, NJ (Address of principal executive offices) 073 |
|
| August 24, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 PROSPECTUS SUPPLEMENT NO. 4 (To the Prospectus dated August 9, 2021) Up to 136,035,264 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 9, 2021 (the “Prospectus”), which form |
|
| August 24, 2021 |
Letter from Crowe LLP to the Securities and Exchange Commission dated August 24, 2021 Exhibit 16.1 August 24, 2021 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, N. E. Washington, D.C. 20549 Ladies and Gentlemen: We have read the comments made regarding us in Item 4.01 of Form 8-K of AvePoint, Inc. dated August 24, 2021, as contained in the first paragraph of Item 4.01, the second and third sentences of the second paragraph of Item 4.01, and the thi |
|
| August 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2021 (August 19, 2021) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (C |
|
| August 16, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39048 AvePoint, |
|
| August 16, 2021 |
424B3 1 avpt20210810424b3.htm FORM 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 PROSPECTUS SUPPLEMENT NO. 3 (To the Prospectus dated August 9, 2021) Up to 136,035,264 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated Augu |
|
| August 16, 2021 |
Employment Agreement, dated January 1, 2021, by and between AvePoint and James Caci. Exhibit 10.1 EXECUTION COPY AVEPOINT, INC. EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is made and entered into by and between AvePoint, Inc., a Delaware corporation (the ?Corporation?), and James Caci (the ?Executive?), and provides as follows: RECITALS WHEREAS, the Corporation is a software company that enables organizations to collaborate with confidence as the largest pro |
|
| August 16, 2021 |
Exhibit 99.1 AvePoint Strengthens Executive Leadership Team Jim Caci will serve as the company?s new CFO and Tom Lin as Chief Operating Officer JERSEY CITY, N.J., August 10, 2021 ? AvePoint, Inc. (NASDAQ: AVPT), the largest data management ISV for Microsoft 365, today announced the expansion of its executive leadership team with the appointment of James (Jim) Caci to Chief Financial Officer and Th |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 (August 10, 2021) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (C |
|
| August 16, 2021 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 PROSPECTUS SUPPLEMENT NO.2 (To the Prospectus dated August 9, 2021) Up to 136,035,264 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 9, 2021 (the ?Prospec |
|
| August 10, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 PROSPECTUS SUPPLEMENT NO. 1 (To the Prospectus dated August 9, 2021) Up to 136,035,264 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 9, 2021 (the ?Prospectus?), which form |
|
| August 10, 2021 |
Exhibit 99.1 AvePoint Operations, Inc. and Subsidiaries (formerly known as AvePoint, Inc.) Condensed Consolidated Balance Sheets (In thousands, except share and per share amounts) (Unaudited) June 30, December 31, 2021 2020 Assets Current assets Cash and cash equivalents $ 66,338 $ 69,112 Short-term investments 1,408 992 Accounts receivable, net of allowance of $1,030 and $1,767 at June 30, 2021 a |
|
| August 10, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 avpt20210809b8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2021 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of |
|
| August 10, 2021 |
424B3 1 d195647d424b3.htm 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-258109 PROSPECTUS Up to 136,029,478 Shares of Common Stock Up to 17,905,000 Shares of Common Stock Issuable Upon Exercise of Warrants Up to 405,000 Warrants to Purchase Common Stock This prospectus relates to the issuance by us of an aggregate of up to 17,905,000 shares of our common stock, $0.0 |
|
| August 10, 2021 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets 8-K/A 1 avpt202107198ka.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2021 (July 1, 2021) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-446 |
|
| August 10, 2021 |
AvePoint Announces Second Quarter 2021 Financial Results Exhibit 99.1 AvePoint Announces Second Quarter 2021 Financial Results JERSEY CITY, NJ - August 10, 2021 ? AvePoint, Inc. (NASDAQ: AVPT), the largest data management solutions provider for Microsoft 365, today announced financial results for the second quarter ended June 30, 2021. ?In the second quarter we delivered record results, with revenue of $45.3 million, up 38% year-over-year, driven by the |
|
| August 10, 2021 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Exhibit 99.2 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of the financial condition and results of operations of AvePoint Operations, Inc. (formerly known as AvePoint, Inc.) and its subsidiaries ("AvePoint" or the "Company") should be read together with the unaudited condensed consolidated financial statements as of Ju |
|
| August 5, 2021 |
AVEPOINT, INC. 525 Washington Blvd, Suite 1400 Jersey City, NJ 07310 August 5, 2021 VIA EDGAR CORRESP 1 filename1.htm AVEPOINT, INC. 525 Washington Blvd, Suite 1400 Jersey City, NJ 07310 August 5, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Jan Woo Priscilla Dao RE: AvePoint, Inc. Registration Statement on Form S-1 File No. 333-258109 Acceleration Request Requested Date: August 9, 2021 Reque |
|
| August 5, 2021 |
S-1/A 1 d195647ds1a.htm S-1/A Table of Contents As filed with the U.S. Securities and Exchange Commission on August 5, 2021. Registration No. 333-258109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 7379 83-4461 |
|
| August 5, 2021 |
Exhibit 21.1 AvePoint, Inc. List of Material Subsidiaries Subsidiary Jurisdiction AvePoint AU Pty Ltd. Australia AvePoint Beijing Technology Ltd. China AvePoint Benelux Netherlands AvePoint Canada Ltd. Canada AvePoint Deutschland GmbH Germany AvePoint EduTech Pte. Ltd. Singapore AvePoint France France AvePoint Holding Limited United Kingdom AvePoint Holdings USA, LLC Virginia (United States) AvePo |
|
| August 2, 2021 |
AVPT / AvePoint, Inc. Class A / Lu Zhijian - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AVEPOINT, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 053604104 (CUSIP Number) Zhijian Lu c/o AvePoint, Inc. 525 Washington Blvd, Suite 1400 Jersey City, NJ 07310 (Name, Address and Telephone Number of Pe |
|
| August 2, 2021 |
AVPT / AvePoint, Inc. Class A / Zhu James Zhijian - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AVEPOINT, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 053604104 (CUSIP Number) James Zhijian Zhu c/o AvePoint, Inc. 525 Washington Blvd, Suite 1400 Jersey City, NJ 07310 (Name, Address and Telephone Numbe |
|
| July 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2021 (July 23, 2021) AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation) (Commi |
|
| July 30, 2021 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER This Agreement And Plan Of Merger (?Agreement?), dated as of July 23, 2021, by and between AvePoint US, LLC, a Delaware limited liability company (the ?LLC?), and AvePoint, Inc., a Delaware corporation (the ?Company?). Recitals A. The Board of Directors of the Company (the ?Board?) and the sole Member of the LLC deem it advisable and in the best interests o |
|
| July 30, 2021 |
Exhibit 10.1 Execution Version ASSIGNMENT AND ASSUMPTION AGREEMENT This ASSIGNMENT and ASSUMPTION AGREEMENT, dated as of July 23, 2021 (this ?Agreement?) is entered into between AvePoint US, LLC (f/k/a Athena Technology Merger Sub 2, LLC), a Delaware limited liability company (the ?Assignor?), and AvePoint, Inc. (f/k/a Apex Technology Acquisition Corporation), a Delaware corporation (the ?Assignee |
|
| July 30, 2021 |
Exhibit 10.2 Execution Version LIMITED CONSENT AND WAIVER TO LOAN AND SECURITY AGREEMENT LIMITED CONSENT AND WAIVER TO LOAN AND SECURITY AGREEMENT, dated as of July 23, 2021 (this ?Consent?), among AVEPOINT US, LLC (f/k/a Athena Technology Merger Sub 2, LLC), a Delaware corporation (the ?Original Borrower?), AVEPOINT, INC. (f/k/a Apex Technology Acquisition Corporation), a Delaware corporation (?H |
|
| July 23, 2021 |
Registration Statement on Form S-1 Table of Contents As filed with the U.S. Securities and Exchange Commission on July 23, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVEPOINT, INC. (Exact name of registrant as specified in its charter) Delaware 7379 83-4461709 (State or other jurisdiction of incorporation or org |
|
| July 21, 2021 |
AVPT / AvePoint, Inc. Class A / Sixth Street Partners Management Company, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AvePoint, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 053604104 (CUSIP Number) Joshua Peck c/o Sixth Street Partners, LLC 2100 McKinney Avenue Suite 1500 Dallas, TX 75201 469-621-3001 (Name, Address and Telephone Number of Person Aut |
|
| July 12, 2021 |
AVPT / AvePoint, Inc. Class A / Gong Xunkai - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AVEPOINT, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 053604104 (CUSIP Number) Xunkai Gong c/o AvePoint, Inc. 525 Washington Blvd, Suite 1400 Jersey City, NJ 07310 (Name, Address and Telephone Numb |
|
| July 12, 2021 |
AVPT / AvePoint, Inc. Class A / Jiang Tianyi - SC 13D Activist Investment SC 13D 1 d179552dsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AVEPOINT, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 053604104 (CUSIP Number) Tianyi Jiang c/o AvePoint, Inc. 525 Washington Blvd, Suite 1400 Jersey City, NJ 07310 (Name |
|
| July 7, 2021 |
Exhibit 10.21 Execution Version LIMITED CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT LIMITED CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT, dated as of July 1, 2021 (this ?Amendment?), among AVEPOINT OPERATIONS, INC. (f/k/a AvePoint, Inc.), a Delaware corporation (?Original Borrower?), APEX TECHNOLOGY ACQUISITION CORP. (?Holdings?), the other guarantors party hereto, and |
|
| July 7, 2021 |
Pledge Agreement, dated July 1, 2021, by and among AvePoint, Inc. and HSBC Ventures USA Inc. Exhibit 10.23 Execution Version PLEDGE AGREEMENT THIS PLEDGE AGREEMENT (this ?Agreement?) is entered into as of July 1, 2021, by and between AVEPOINT, INC. (f/k/a APEX TECHNOLOGY ACQUISITION CORP.), a Delaware corporation (?Pledgor?) and HSBC VENTURES USA INC. (?Bank?). RECITALS WHEREAS, Bank is party to the Loan and Security Agreement, dated as of April 7, 2020 (as amended by the Limited Consent |
|
| July 7, 2021 |
Limited Guaranty, dated July 1, 2021, by and among AvePoint, Inc. and HSBC Ventures USA Inc. Exhibit 10.24 Execution Version LIMITED GUARANTY This LIMITED GUARANTY (this ?Guaranty?) is made as of July 1, 2021, by AVEPOINT, INC. (f/k/a APEX TECHNOLOGY ACQUISITION CORP.), a Delaware corporation (?Guarantor?), in favor of HSBC VENTURES USA INC. (?Bank?). RECITALS WHEREAS, pursuant to the terms of the Loan and Security Agreement, dated as of April 7, 2020 (as amended by the Limited Consent an |
|
| July 7, 2021 |
Exhibit 21.1 AvePoint, Inc. List of Material Subsidiaries Subsidiary Jurisdiction AvePoint AU Pty Ltd. Australia AvePoint Beijing Technology Ltd. China AvePoint Benelux Netherlands AvePoint Canada Ltd. Canada AvePoint Deutschland GmbH Germany AvePoint EduTech Pte. Ltd. Singapore AvePoint France France AvePoint Holding Limited United Kingdom AvePoint Holdings USA, LLC Virginia (United States) AvePo |
|
| July 7, 2021 |
AvePoint Closes Business Combination; to Begin Trading on Nasdaq as “AVPT” EX-99.1 Exhibit 99.1 AvePoint Closes Business Combination; to Begin Trading on Nasdaq as “AVPT” JERSEY CITY, N.J.—July 1, 2021– AvePoint, Inc. (“AvePoint” or the “Company”), the largest Microsoft 365 data management solutions provider, announced today the completion of its previously announced business combination with Apex Technology Acquisition Corporation (“Apex”), a publicly traded special pur |
|
| July 7, 2021 |
Amended and Restated Certificate of Incorporation of AvePoint, Inc. Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF APEX TECHNOLOGY ACQUISITION CORPORATION July 1, 2021 Apex Technology Acquisition Corporation, a corporation organized and existing under the General Corporation Law of the State of Delaware (as it now exists or may hereafter be amended and supplemented, the ?DGCL?), does hereby certify that: ONE: The original Certificate of In |
|
| July 7, 2021 |
Form of Stock Option Grant Package under AvePoint, Inc. 2021 Equity Incentive Plan. Exhibit 10.13 EXECUTION FORM AVEPOINT, INC. STOCK OPTION GRANT NOTICE (2021 EQUITY INCENTIVE PLAN) AvePoint, Inc. (the ?Company?), pursuant to the Company?s 2021 Equity Incentive Plan (the ?Plan?), has granted to you (?Optionholder?) an option to purchase the number of shares of the Common Stock set forth below (the ?Option?). Your Option is subject to all of the terms and conditions as set forth |
|
| July 7, 2021 |
Letter from WithumSmith+Brown, PC Exhibit 16.1 July 7, 2021 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Ladies and Gentlemen: We have read AvePoint, Inc.?s statements (formerly known as Apex Technology Acquisition Corporation) included under Item 4.01 of its Form 8-K dated July 7, 2021. We agree with the statements concerning our Firm under Item 4.01, in which we were i |
|
| July 7, 2021 |
Exhibit 10.4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of July 1, 2021, is made and entered into by and among AvePoint Holdings, Inc., a Delaware corporation (f/k/a Apex Technology Acquisition Corp.) (the ?Company?), Apex Technology Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), Cantor |
|
| July 7, 2021 |
Form of Stock Option Grant Package under AvePoint 2006 Equity Incentive Plan Exhibit 10.7 AVEPOINT, INC. 2006 EQUITY INCENTIVE PLAN FY 2013 OFFICER STOCK OPTION AWARD (Time Vesting) NUMBER OF PRICE PER SOCIAL SHARES SUBJECT TO SECURITY GRANTED TO GRANT DATE THIS OPTION AWARD SHARE NUMBER [Name] November 22, 2013 [No. of Shares] $13.46 [SSN] GRANT NUMBER OPTION VESTING SCHEDULE SO-2013-xx Subject to the other terms contained in this Award, the options awarded hereunder shal |
|
| July 7, 2021 |
Amended and Restated Bylaws of AvePoint, Inc. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF AVEPOINT, INC. As adopted on July 1, 2021 AMENDED AND RESTATED BYLAWS OF AVEPOINT, INC. (a Delaware corporation) TABLE OF CONTENTS Page Article I OFFICES 1 1.1 Registered Office 1 1.2 Offices 1 Article II MEETINGS OF STOCKHOLDERS 1 2.1 Location 1 2.2 Timing 1 2.3 Notice of Meeting 1 2.4 Stockholders? Records 1 2.5 Special Meetings 2 2.6 Notice of Meeting |
|
| July 7, 2021 |
Exhibit 10.22 Execution Version ASSIGNMENT AND ASSUMPTION AGREEMENT This ASSIGNMENT and ASSUMPTION AGREEMENT, dated as of July 1, 2021 (this ?Agreement?) is entered into between AvePoint Operations, Inc. (f/k/a AvePoint, Inc.), a Delaware corporation (the ?Assignor?), and AvePoint US, LLC (f/k/a Athena Technology Merger Sub 2, LLC), a Delaware limited liability company (the ?Assignee?), and consen |
|
| July 7, 2021 |
Form of RSU Grant Package under AvePoint, Inc. 2021 Equity Incentive Plan. Exhibit 10.14 EXECUTION FORM AVEPOINT, INC. RSU AWARD GRANT NOTICE (2021 EQUITY INCENTIVE PLAN) AvePoint, Inc. (the ?Company?) has awarded to you (the ?Participant?) the number of restricted stock units specified and on the terms set forth below in consideration of your services (the ?RSU Award?). Your RSU Award is subject to all of the terms and conditions as set forth herein and in the Company?s |
|
| July 7, 2021 |
Form of RSU Grant Package under 2006 Equity Incentive Plan. Exhibit 10.8 AVEPOINT, INC. 2006 EQUITY INCENTIVE PLAN FY 2013 RESTRICTED STOCK AWARD (Time Vesting) SOCIAL NUMBER OF PRICE PER SECURITY ISSUED TO ISSUE DATE SHARES ISSUED SHARE NUMBER [Name] November 29, 2013 [No. of Shares] $13.46 [SSN] GRANT NUMBER RESTRICTION LAPSE SCHEDULE RS-2013-xx Subject to the other terms contained in this Award, [no. of shares divided by 4] shares will vest on December |
|
| July 7, 2021 |
AvePoint 2006 Equity Incentive Plan. Exhibit 10.6 AVEPOINT, INC. 2006 EQUITY INCENTIVE PLAN 1. PURPOSES. (a) Eligible Stock Award Recipients. The persons eligible to receive Stock Awards are Employees, Directors and Consultants. (b) Available Stock Awards. The purpose of the Plan is to provide a means by which eligible recipients of Stock Awards may be given an opportunity to benefit from increases in value of the Common Stock throug |
|
| July 7, 2021 |
8-K 1 d196379d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2021 AvePoint, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of incorporation |
|
| July 1, 2021 |
Submission of Matters to a Vote of Security Holders 8-K 1 d164074d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2021 APEX TECHNOLOGY ACQUISITION CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-39048 83-4461709 (State or Other Jurisdi |
|
| June 23, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 22, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 21, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 17, 2021 |
425 1 d167756d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 EXPLANATORY NOTE On June 15, 2021, Jeff Epstein, Co-CEO of Apex Technology Acquisition Corporation, and |
|
| June 17, 2021 |
425 1 d167756d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 EXPLANATORY NOTE On June 17, 2021, messages were sent via email to certain holders of record of the Comp |
|
| June 14, 2021 |
425 1 d161774d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 EXPLANATORY NOTE On June 12, 2021, messages were sent via email to certain holders of record of the Comp |
|
| June 14, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 11, 2021 |
425 1 d175062d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 EXPLANATORY NOTE On June 11, 2021, certain employees and members of management of each of Apex Technolog |
|
| June 10, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 8, 2021 |
425 1 d175062d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 EXPLANATORY NOTE On June 8, 2021, Jeff Epstein, Co-CEO of Apex Technology Acquisition Corporation, appea |
|
| June 7, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 7, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 7, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 3, 2021 |
Filed by Apex Technology Acquisition Corporation Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| June 3, 2021 |
Filed by Apex Technology Acquisition Corporation 425 1 d175062d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 Investor Presentation June 2021 Collaborate with Confidence Accessible content is available upon request |
|
| June 2, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| June 2, 2021 |
Apex Technology Acquisition Corporation 425 1 d175062d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 Apex Technology Acquisition Corporation Dear Fellow Shareholder, We hope you and your family are well. T |
|
| June 2, 2021 |
Filed by Apex Technology Acquisition Corporation 425 1 d175062d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 Investor Presentation June 2021 Collaborate with Confidence Accessible content is available upon request |
|
| June 2, 2021 |
APEX TECHNOLOGY ACQUISITION CORPORATION 533 Airport Blvd Suite 400 Burlingame, CA 94010 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-252712 APEX TECHNOLOGY ACQUISITION CORPORATION 533 Airport Blvd Suite 400 Burlingame, CA 94010 Dear Apex Technology Acquisition Corporation Stockholders: Apex Technology Acquisition Corporation, a Delaware corporation (?Apex?), Athena Technology Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Apex (?M |
|
| June 1, 2021 |
APEX TECHNOLOGY ACQUISITION CORPORATION 533 Airport Blvd Suite 400 Burlingame, California, 94010 APEX TECHNOLOGY ACQUISITION CORPORATION 533 Airport Blvd Suite 400 Burlingame, California, 94010 June 1, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| May 28, 2021 |
Exhibit 99.8 PRELIMINARY PROXY CARD?SUBJECT TO COMPLETION Apex Technology Acquisition Corporation SPECIAL MEETING OF STOCKHOLDERS , 2021 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF Apex Technology Acquisition Corporation The undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the Notice of Special Meeting and Proxy Statement in con |
|
| May 28, 2021 |
As filed with the Securities and Exchange Commission on May 28, 2021 Table of Contents As filed with the Securities and Exchange Commission on May 28, 2021 Registration No. |
|
| May 28, 2021 |
APEX TECHNOLOGY ACQUISITION CORPORATION 533 Airport Blvd Suite 400 Burlingame, California, 94010 CORRESP 1 filename1.htm APEX TECHNOLOGY ACQUISITION CORPORATION 533 Airport Blvd Suite 400 Burlingame, California, 94010 May 28, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mitchell Austin, Staff Attorney Re: Apex Technology Acquisition Corporation Registration Statement on Form S-4 File No. 333-252712 Ladies and |
|
| May 26, 2021 |
Apex Technology Acquisition Corp. and AvePoint to Participate at Upcoming Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| May 20, 2021 |
Amended and Restated Bylaws of Combined Company. EX-3.5 2 d270676dex35.htm EX-3.5 Exhibit 3.5 AMENDED AND RESTATED BYLAWS OF AVEPOINT, INC. As adopted on , 2021 AMENDED AND RESTATED BYLAWS OF AVEPOINT, INC. (a Delaware corporation) TABLE OF CONTENTS Page Article I OFFICES 1 1.1 Registered Office 1 1.2 Offices 1 Article II MEETINGS OF STOCKHOLDERS 1 2.1 Location 1 2.2 Timing 1 2.3 Notice of Meeting 1 2.4 Stockholders’ Records 1 2.5 Special Meetin |
|
| May 20, 2021 |
Consent of Jeff Epstein to be named as a director. Exhibit 99.3 May 14, 2021 Apex Technology Acquisition Corporation 533 Airport Blvd, Suite 400 Burlingame, CA 94010 Consent to Reference in Proxy Statement/Prospectus Apex Technology Acquisition Corporation (the ?Company?) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?). In connection ther |
|
| May 20, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on May 19, 2021 Registration No. |
|
| May 20, 2021 |
Consent of Stephen CuUnjieng to be named as a director. EX-99.4 Exhibit 99.4 May 14, 2021 Apex Technology Acquisition Corporation 533 Airport Blvd, Suite 400 Burlingame, CA 94010 Consent to Reference in Proxy Statement/Prospectus Apex Technology Acquisition Corporation (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connect |
|
| May 20, 2021 |
Form of Amendment No. 1 to PIPE Subscription Agreements Exhibit 10.15 FORM OF AMENDMENT NO. 1 TO SUBSCRIPTION AGREEMENT This Amendment No. 1 (this “Amendment”) to the Subscription Agreement, dated November 23, 2020 (the “Subscription Agreement”), by and between Apex Technology Acquisition Corp., a Delaware corporation (“Apex”), and the undersigned subscriber (the “Investor”), is made and entered into as of April , 2021 by and among Apex and the Investo |
|
| May 20, 2021 |
Form of Indemnification Agreement. Exhibit 10.29 FORM OF INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the ?Agreement?) is made and entered into as of , 2020 between AvePoint, Inc., a Delaware corporation (the ?Company?), and (?Indemnitee?). WITNESSETH THAT: WHEREAS, highly competent persons have become more reluctant to serve corporations as directors or in other capacities unless they are provided with adequate protec |
|
| May 20, 2021 |
Consent of Brian Brown to be named as a director. Exhibit 99.2 May 14, 2021 Apex Technology Acquisition Corporation 533 Airport Blvd, Suite 400 Burlingame, CA 94010 Consent to Reference in Proxy Statement/Prospectus Apex Technology Acquisition Corporation (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection ther |
|
| May 20, 2021 |
Apex Technology Acquisition Corporation and AvePoint Announce First Quarter 2021 Financial Results 425 1 d157173d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 And deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 Apex Technology Acquisition Corporation and AvePoint Announce First Quarter 2021 Financial Results BURLI |
|
| May 20, 2021 |
Consent of Jeff Teper to be named as a director. Exhibit 99.6 May 14, 2021 Apex Technology Acquisition Corporation 533 Airport Blvd, Suite 400 Burlingame, CA 94010 Consent to Reference in Proxy Statement/Prospectus Apex Technology Acquisition Corporation (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection ther |
|
| May 20, 2021 |
Specimen Common Stock Certificate. EX-4.4 3 d270676dex44.htm EX-4.4 Exhibit 4.4 EX-4.4 SPECIMEN COMMON STOCK CERTIFICATE NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 053604 104 AvePoint, Inc. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE COMMON STOCK OF AvePoint, Inc. (THE “COMPAN |
|
| May 20, 2021 |
Consent of Xunkai Gong to be named as a director. Exhibit 99.7 May 14, 2021 Apex Technology Acquisition Corporation 533 Airport Blvd, Suite 400 Burlingame, CA 94010 Consent to Reference in Proxy Statement/Prospectus Apex Technology Acquisition Corporation (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection ther |
|
| May 20, 2021 |
Consent of John Ho to be named as a director. Exhibit 99.5 May 14, 2021 Apex Technology Acquisition Corporation 533 Airport Blvd, Suite 400 Burlingame, CA 94010 Consent to Reference in Proxy Statement/Prospectus Apex Technology Acquisition Corporation (the ?Company?) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?). In connection ther |
|
| May 20, 2021 |
EX-99.8 15 d270676dex998.htm EX-99.8 Exhibit 99.8 PRELIMINARY PROXY CARD—SUBJECT TO COMPLETION Apex Technology Acquisition Corporation SPECIAL MEETING OF STOCKHOLDERS , 2021 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF Apex Technology Acquisition Corporation The undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the Notice of Speci |
|
| May 20, 2021 |
Consent of Tianyi Jiang to be named as a director. EX-99.1 8 d270676dex991.htm EX-99.1 Exhibit 99.1 May 14, 2021 Apex Technology Acquisition Corporation 533 Airport Blvd, Suite 400 Burlingame, CA 94010 Consent to Reference in Proxy Statement/Prospectus Apex Technology Acquisition Corporation (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “ |
|
| May 19, 2021 |
Exhibit 10.1 THIS PROMISSORY NOTE (?NOTE?) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| May 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39048 Apex Technology Acquisition |
|
| May 19, 2021 |
140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com FIRM / AFFILIATE OFFICES Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo Washington, D.C. VIA EDGAR |
|
| May 19, 2021 |
Amendment No. 1 to Warrant Agreement Exhibit 10.2 Apex Technology Acquisition Corp. Amendment No. 1 to Warrant Agreement WHEREAS, Apex Technology Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company (the “Warrant Agent”) entered into a Warrant Agreement dated September 16, 2019 (the “Original Warrant Agreement’); WHEREAS, Section 9.8 of the Original Warrant Agreement, as amended, provides that amendments m |
|
| May 19, 2021 |
Filed by Apex Technology Acquisition Corporation 425 1 d157173d425.htm 425 Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 And deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. 001-39048 Company Name: AvePoint, Inc. Event: Jefferies Virtual RSA Booth Tour Date: May 18, 2021 Brent Thill, Ana |
|
| May 19, 2021 |
140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com FIRM /AFFILIATE OFFICES Beijing Boston Brussels Century City Chicago Dubai D?sseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo Washington, D.C. May 19, 202 |
|
| May 19, 2021 |
EX-10.3 4 f10q0321ex10-3apextech.htm AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION Exhibit 10.3 Execution Version AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION This Amendment No. 3 (this “Amendment”) to the Business Combination Agreement and Plan of Reorganization, dated as of November 23, 2020, as amended by Amendment No. 1 thereto, da |
|
| May 18, 2021 |
NT 10-Q 1 ea141033-nt10qapextechno.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission file number: 001-39048 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on |
|
| May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39048 Apex Tec |
|
| May 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 12, 2021 (May 6, 2021) APEX TECHNOLOGY ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-39048 83-4461709 (State or other jurisdiction of |
|
| April 28, 2021 |
CORRESP 1 filename1.htm 140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com FIRM / AFFILIATE OFFICES Beijing Moscow Boston Munich Brussels New York Century City Orange County Chicago Paris Dubai Riyadh Düsseldorf San Diego Frankfurt San Francisco Hamburg Seoul Hong Kong Shanghai Houston Silicon Valley London Singapore Los Angeles Tokyo Madrid Washingto |
|
| April 14, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 And deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| April 2, 2021 |
Exhibit 99.7 PRELIMINARY PROXY CARD—SUBJECT TO COMPLETION Apex Technology Acquisition Corporation SPECIAL MEETING OF STOCKHOLDERS , 2021 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF Apex Technology Acquisition Corporation The undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the Notice of Special Meeting and Proxy Statement in con |
|
| April 2, 2021 |
140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com FIRM /AFFILIATE OFFICES Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo Washington, D.C. April 1, 20 |
|
| April 2, 2021 |
As filed with the Securities and Exchange Commission on April 1, 2021 S-4/A Table of Contents As filed with the Securities and Exchange Commission on April 1, 2021 Registration No. |
|
| April 1, 2021 |
140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com FIRM /AFFILIATE OFFICES Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo Washington, D.C. April 1, 20 |
|
| March 22, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| March 11, 2021 |
140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com FIRM /AFFILIATE OFFICES Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo Washington, D.C. March 10, 2 |
|
| March 11, 2021 |
425 1 d270676d425.htm 425 Filed by Apex Technology Acquisition Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No.: 001-39048 Apex Technology Acquisition Corporation and AvePoint Announce Record Full Year 2020 Financial Result |
|
| March 11, 2021 |
Exhibit 99.7 PRELIMINARY PROXY CARD?SUBJECT TO COMPLETION Apex Technology Acquisition Corporation SPECIAL MEETING OF STOCKHOLDERS , 2021 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF Apex Technology Acquisition Corporation The undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the Notice of Special Meeting and Proxy Statement in con |
|
| March 11, 2021 |
As filed with the Securities and Exchange Commission on March 10, 2021 Table of Contents As filed with the Securities and Exchange Commission on March 10, 2021 Registration No. |
|
| March 9, 2021 |
Exhibit 2.1 Execution Version AMENDMENT NO. 2 TO BUSINESS COMBINATION AGREEMENT AND PLAN OF REORGANIZATION This Amendment No. 2 (this ?Amendment?) to the Business Combination Agreement and Plan of Reorganization, dated as of November 23, 2020, as amended by Amendment No. 1 thereto, dated as of December 30, 2020 (the ?Business Combination Agreement?), by and among by and among Apex Technology Acqui |
|
| March 9, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 d109161d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 8, 2021 APEX TECHNOLOGY ACQUISITION CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-39048 83-4461709 (State or Other Jurisdi |
|
| March 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39048 Apex Technology Acquisition |
|
| February 19, 2021 |
Filed by Apex Technology Acquisition Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Apex Technology Acquisition Corporation Commission File No. |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Apex Technology Acquisition Corporation (Name of Issuer) Class A common stock, $0.0001 par value per share (Title of Class of Securities) 03768F102 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropr |
|
| February 12, 2021 |
EXHIBIT 2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENT, that I, Michael Edward Platt, hereby make, constitute and appoint Steven Pariente, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as principal of, or in other capacities with, BlueCrest Capital Management Limited, a company organized under the |
|
| February 12, 2021 |
EX-99.1 2 brhc10019814ex99-1.htm EXHIBIT 1 EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* APEX TECHNOLOGY ACQUISITION CORPORATION (Name of Issuer) UNITS (Title of Class of Securities) 03768F201 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
